Company news
Jinyu Bio-technology Co., Ltd. Class A (SSE:600201) news
Jinyu Bio-technology Co., Ltd. Class A news releases on 6ix. Latest, Sep 10, 2026: Rumah 2: A Beam of Light in the Desert
Press releases & updates
Rumah 2: A Beam of Light in the Desert
September 10, 2026
"Jinyu Bio-Technology Co., Ltd."Announcement on Implementation Results of Share Repurchase and Share Changes
September 7, 2026
"Jinyu Bio-Technology Co., Ltd."Announcement on Convening the 2026 Semi-annual Performance Briefing
August 25, 2026
"Jinyu Bio-Technology Co., Ltd."Announcement on Dissolution, Liquidation and Deregistration of an Investment Fund Established with the Company's Participation
August 12, 2026
"Jinyu Bio-Technology Co., Ltd."Indicative Announcement on Changes in Equity Interests of Shareholders Holding More Than 5% of the Shares and Their Persons Acting in Concert Reaching the 1% Threshold
August 10, 2026
"Jinyu Bio-Technology Co., Ltd."Announcement on Progress in Repurchasing Shares through Call Auction
August 3, 2026
"Jinyu Bio-Technology Co., Ltd."Announcement on the Subsidiary Obtaining Approval to Manufacture Multivalent Foot-and-Mouth Disease Vaccine (SAT 1)
July 21, 2026
"Jinyu Bio-Technology Co., Ltd."Announcement on the Completion of the Cancellation of Repurchased Shares and Share Changes
July 20, 2026
"Jinyu Bio-Technology Co., Ltd."Announcement on Expected Increase in Semi-annual Performance for 2026
July 5, 2026
"Jinyu Bio-Technology Co., Ltd."Announcement on Subscription of Private Equity Shares
July 1, 2026
Announcement on Initially Repurchasing the Company's Shares through Call Auction
June 26, 2026
Announcement on Implementation of Dividend Distribution for 2025
June 15, 2026
Announcement on Obtaining Letter of Commitment for Special Loans for Stock Repurchase from Financial Institution
June 12, 2026
Announcement on Shareholding of Top 10 Shareholders and Top 10 Shareholders Without Sales Limit Concerning Shares Repurchase
June 11, 2026
Scheme for Repurchasing Shares through Call Auction
June 5, 2026
Indicative Announcement on Chairman's Proposal to Repurchase Company Shares
June 3, 2026
Announcement on Pledge of Shares Held by Shareholders
June 1, 2026
Announcement on Attending Online Collective Reception Day for Investors of Listed Companies in Inner Mongolia Jurisdiction in 2026
May 22, 2026
Announcement on Notifying Creditors of Repurchase and Cancellation of Partial Stock, as well as Reducing Registered Capital
May 18, 2026
Announcement on Convening Performance Briefing for 2025 and Q1 2026
May 12, 2026
Announcement on Using Idle Self-owned Funds for Cash Management
April 22, 2026
Announcement on the Approval for the Subsidiary to Produce Emergency Immune Fowl Pox Vaccine
April 7, 2026
Announcement on the Subsidiary Obtaining New Veterinary Drug Registration Certificate
March 26, 2026
Announcement on Completing Industrial and Commercial Change Registration
February 6, 2026
Announcement on Release of Pledge of Shareholder's Shares
February 3, 2026
Announcement on the 1st Share Increase by Majority Shareholder and Progress in the Implementation of Share Increase Plan
January 6, 2026
Announcement on Major Shareholder Obtaining Commitment Letter for Shareholding Increase Special Loan
December 24, 2025
Announcement on Share Increase Plan for Major Shareholders
December 23, 2025
Announcement on Convening the Q3 2025 Performance Briefing
November 17, 2025
Announcement on Implementation Result of Shares Repurchase and Share Changes
October 30, 2025
Announcement on Proposed Repurchase and Cancellation of Partial Stocks under the 2023 Employee Stock Ownership Plan
October 27, 2025
Announcement on the Change of Name of Holding Subsidiary and Completion of Industrial and Commercial Change Registration
October 13, 2025
Announcement on Progress in Repurchasing Shares through Call Auction
October 9, 2025
Announcement on Convening the 2025 Semi-annual Performance Briefing
September 15, 2025
Announcement on Resolutions of the 3rd Meeting of the 12th Board of Directors
August 19, 2025
Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares Reaching 1% Scale
August 1, 2025
Announcement on the Implementation of Partial Share Repurchase and Cancellation under the 2023 Employee Stock Ownership Plan
July 28, 2025
Announcement on Subsidiary Obtaining Clinical Trial Approval for Veterinary Biological Products
July 25, 2025
Announcement on Receipt of Warning Letter from China Securities Regulatory Commission Inner Mongolia Office by the Company and Relevant Personnel
July 24, 2025
Announcement on Abnormal Fluctuations in Stock Trading
July 17, 2025
Announcement on Resolutions of the 2nd Meeting of the 12th Board of Directors
July 14, 2025
Announcement on Attending the 2025 Online Collective Reception Day for Investors in Inner Mongolia Jurisdiction
July 9, 2025
Announcement on Adjusting Upper Limit of Share Repurchase Price after Implementation of Dividend Distribution for 2024
June 30, 2025
Announcement on Implementation of Dividend Distribution for 2024
June 19, 2025
Announcement on Transferring Investment Fund Shares
June 9, 2025
Announcement on Resolution of the 1st Meeting of the 12th Board of Directors
May 28, 2025
Announcement on Convening the 2024 Annual and Q1 2025 Performance Briefing
May 19, 2025
Notice on Convening the 2024 Annual General Meeting
May 6, 2025
Announcement on Renewing Engagement of Accounting Firm
April 24, 2025
Announcement on Release of Pledge on Shareholders' Shares
April 2, 2025